GFG
ACHV icon

Goldstone Financial Group’s Achieve Life Sciences ACHV Stock Holding History

Goldstone Financial Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,163
Closed -$71K – 244
2026
Q1 		$71K Hold
24,163
– – 0.01% 225
2025
Q4 		$120K Buy
+24,163
New +$105K 0.01% 215

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Goldstone Financial Group's ACHV Position: Q2 2026 in Review

Goldstone Financial Group sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 24,163 shares — an estimated $71K sold.

Goldstone Financial Group first reported a position in ACHV in Q4 2025 and held it in 2 quarters. The position peaked at $120K in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Goldstone Financial Group reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Goldstone Financial Group sold 24,163 Achieve Life Sciences shares in Q2 2026, an estimated $71K.
  • Goldstone Financial Group first reported a position in Achieve Life Sciences in Q4 2025 and held it in 2 quarters.
  • Goldstone Financial Group's Achieve Life Sciences position peaked at $120K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Goldstone Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.